All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

How nitrosamine contamination is transforming pharmaceutical quality control standards

By

Kiran Kumar Kurella, special to C&EN

8d ago· 6 min readenInsight

Summary

The article discusses how nitrosamine contamination discovered in 2018 in angiotensin receptor blocker medicines has fundamentally transformed pharmaceutical quality control. What began as a crisis with global recalls and regulatory investigations has evolved into a defining benchmark for the pharmaceutical sector. The contaminants, once viewed as anomalies, are now catalyzing a sea change in how the industry approaches quality assurance and impurity testing.

Source

bskyHow nitrosamine contamination is transforming pharmaceutical quality control standardscen.acs.org

Key quotes

· 3 pulled
A pharmaceutical quality crisis involving nitrosamine contamination began in 2018 with the discovery of N-nitrosodimethylamine, a type of nitrosamine, in angiotensin receptor blocker medicines, triggering global recalls, regulatory investigations
Once viewed as anomalies, the contaminants have become a defining benchmark for the pharmaceutical sector
Nitrosamines are catalyzing a sea change in pharma quality control
Snippet from the RSS feed
Once viewed as anomalies, the contaminants have become a defining benchmark for the pharmaceutical sector

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.